Sinopharm Tech (8156) Announces Board Meeting Date for Interim Results

Bulletin Express

Feb 11

Sinopharm Tech Holdings Limited (Stock Code: 8156) has scheduled a board meeting on 26 February 2026. The meeting is set to review and approve interim results for the six-month period ended 31 December 2025 and consider any potential dividend declaration.

The announcement, dated 11 February 2026, confirms that the board will discuss these key matters, and further details will be released pending the outcome of the meeting. The company’s executive directors are Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi, while Mr. Lau Fai Lawrence, Mr. Heung Pik Lun, Mr. Diu Peter, and Mr. Yu Ping Ming serve as independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1196957301"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196957301\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196957301?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-11 18:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196957301","market":"hk","top_or_hot":-1,"title":"Sinopharm Tech (8156) Announces Board Meeting Date for Interim Results","media":"Bulletin Express","content":"<p>Sinopharm Tech Holdings Limited (Stock Code: 8156) has scheduled a board meeting on 26 February 2026. The meeting is set to review and approve interim results for the six-month period ended 31 December 2025 and consider any potential dividend declaration.</p>\n<p>The announcement, dated 11 February 2026, confirms that the board will discuss these key matters, and further details will be released pending the outcome of the meeting. The company’s executive directors are Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi, while Mr. Lau Fai Lawrence, Mr. Heung Pik Lun, Mr. Diu Peter, and Mr. Yu Ping Ming serve as independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Tech (8156) Announces Board Meeting Date for Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Tech (8156) Announces Board Meeting Date for Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-11 18:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinopharm Tech Holdings Limited (Stock Code: 8156) has scheduled a board meeting on 26 February 2026. The meeting is set to review and approve interim results for the six-month period ended 31 December 2025 and consider any potential dividend declaration.</p>\n<p>The announcement, dated 11 February 2026, confirms that the board will discuss these key matters, and further details will be released pending the outcome of the meeting. The company’s executive directors are Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi, while Mr. Lau Fai Lawrence, Mr. Heung Pik Lun, Mr. Diu Peter, and Mr. Yu Ping Ming serve as independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08156","symbol_name":"国药科技股份","start_time":0,"source_url":"","article_id":"1196957301","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196957301","pubTimestamp":1770804328,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinopharm Tech Holdings Limited (Stock Code: 8156) has scheduled a board meeting on 26 February 2026. The meeting is set to review and approve interim results for the six-month period ended 31...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08156":"国药科技股份"},"translate_title":"国药科技(8156)公布中期业绩董事会会议日期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08156":1},"content_text":"Sinopharm Tech Holdings Limited (Stock Code: 8156) has scheduled a board meeting on 26 February 2026. The meeting is set to review and approve interim results for the six-month period ended 31 December 2025 and consider any potential dividend declaration.\nThe announcement, dated 11 February 2026, confirms that the board will discuss these key matters, and further details will be released pending the outcome of the meeting. The company’s executive directors are Mr. Chiu Sin Nang Kenny and Ms. Kwok Shuk Yi, while Mr. Lau Fai Lawrence, Mr. Heung Pik Lun, Mr. Diu Peter, and Mr. Yu Ping Ming serve as independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}